연구성과로 돌아가기
2024 연구성과별 연구자 정보 (368 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Cilia-deficient renal tubule cells are primed for injury with mitochondrial defects and aberrant tryptophan metabolism | Lipschutz, Joshua H. | Lipschutz, JH | 12 | 교신저자 | Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA | Lipschut@musc.edu; | ||||
| Cilia-deficient renal tubule cells are primed for injury with mitochondrial defects and aberrant tryptophan metabolism | Lipschutz, Joshua H. | Lipschutz, JH | 12 | 교신저자 | Ralph H Johnson Vet Affairs Hlth Care Syst, Dept Med, Charleston, SC 29401 USA | Lipschut@musc.edu; | ||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Lee, Yu Rim | Lee, YR | 1 | Kyungpook Natl Univ, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Kim, Gyeonghwa | Kim, G | 2 | Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Kweon, Young Oh | Kweon, YO | 3 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Tak, Won Young | Tak, WY | 4 | Kyungpook Natl Univ, Coll Med, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Park, Soo Young | Park, SY | 5 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Jang, Se Young | Jang, SY | 6 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Lee, Jeong Hwa | Lee, JH | 7 | Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Daegu, South Korea | KIK-0962-2024 | Lee, Jeong-hwa | ||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Park, Min Hwa | Park, MH | 8 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Daegu, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Park, Jung Gil | Park, JG | 9 | Yeungnam Univ, Coll Med, Gyongsan, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Kang, Min Kyu | Kang, MK | 10 | Yeungnam Univ, Coll Med, Gyongsan, South Korea | U-8050-2018 | Kang, Min | ||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Song, Jeong Eun | Song, JE | 11 | Daegu Catholic Univ, Sch Med, Gyongsan, South Korea | ||||||
| CIRCULATING EXOPD-L1 PREDICTS THE OUTCOME OF PATIENTS WITH HCC WHO RECEIVED ATEZOLIZUMAB-BEVACIZUMAB | Hur, Keun | Hur, K | 12 | Kyungpook Natl Univ, Cell & Matrix Res Inst, Sch Med, Daegu, South Korea | G-9513-2011 | Hur, Keun | ||||
| Circulating-tumor DNA Assessment in Diffuse Large B-cell Lymphoma to Determine Up-front Stem Cell Transplantation: A Pilot Study | Kim, Juhyung | Kim, J | 1 | Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea | jhmoon@knu.ac.kr;baekdw83@gmail.com; |
페이지 이동: